Table 3. BMI, CRP and tested marker levels in IGRA-positive and -negative subgroups in the no-symptom group.
| IGRA-negative (N = 29) | IGRA-positive (N = 55) | ||||
| marker | adjusted meana | (95%CI) | adjusted meana | (95%CI) | P values (ANCOVA) |
| BMI (kg/m2) | 21.52 | (20.58–22.46) | 21.48 | (20.74–22.22) | 0.9392 |
| CRP (µg/ml) | 1.12 | (0.60–2.08) | 1.30 | (0.80–2.12) | 0.6663 |
| Adiponectin (µg/ml) | 7.19 | (5.67–9.11) | 6.39 | (5.30–7.70 ) | 0.3792 |
| Leptin (ng/ml) | 4.50 | (3.34–6.05) | 4.38 | (3.47–5.54) | 0.8783 |
| Leptin/adiponectin ratio | 0.63 | (0.40–0.97) | 0.69 | (0.49–0.97) | 0.7080 |
| Fetuin-A (µg/ml) | 234.22 | (212.40–258.29) | 263.88 | (244.26–285.06) | 0.0333 |
| RBP4 (µg/ml) | 39.64 | (32.28–48.69) | 42.88 | (36.45–50.43) | 0.4997 |
a
Estimated means of plasma concentrations were compared after logarithmic transformation, being adjusted for gender and age as covariates. The data shown are transformed back to the original unit.
No P values were statistically significant when the significance level is set as P<0.007 based on the Bonferrroni correction.